These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

443 related articles for article (PubMed ID: 22721665)

  • 1. The effect of patent foramen ovale closure on visual aura without headache or typical aura with migraine headache.
    Khessali H; Mojadidi MK; Gevorgyan R; Levinson R; Tobis J
    JACC Cardiovasc Interv; 2012 Jun; 5(6):682-7. PubMed ID: 22721665
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Primary transcatheter patent foramen ovale closure is effective in improving migraine in patients with high-risk anatomic and functional characteristics for paradoxical embolism.
    Rigatelli G; Dell'Avvocata F; Ronco F; Cardaioli P; Giordan M; Braggion G; Aggio S; Chinaglia M; Rigatelli G; Chen JP
    JACC Cardiovasc Interv; 2010 Mar; 3(3):282-7. PubMed ID: 20298985
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Visual migraine aura with or without headache: association with right to left shunt and assessment following transcutaneous closure.
    Mojadidi MK; Khessali H; Gevorgyan R; Levinson RD; Tobis JM
    Clin Ophthalmol; 2012; 6():1099-105. PubMed ID: 22888208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Migraine and percutaneous patent foramen ovale closure: a systematic review and meta-analysis.
    Shi YJ; Lv J; Han XT; Luo GG
    BMC Cardiovasc Disord; 2017 Jul; 17(1):203. PubMed ID: 28747203
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is it too early to recommend patent foramen ovale closure for all patients who suffer from migraine? A single-centre study.
    Chessa M; Colombo C; Butera G; Negura D; Piazza L; Varotto L; Bussadori C; Fesslova V; Meola G; Carminati M
    J Cardiovasc Med (Hagerstown); 2009 May; 10(5):401-5. PubMed ID: 19449455
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Percutaneous closure of patent foramen ovale for migraine headaches refractory to medical treatment.
    Wahl A; Praz F; Findling O; Nedeltchev K; Schwerzmann M; Tai T; Windecker S; Mattle HP; Meier B
    Catheter Cardiovasc Interv; 2009 Jul; 74(1):124-9. PubMed ID: 19180663
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improvement of migraine headaches after percutaneous closure of patent foramen ovale for secondary prevention of paradoxical embolism.
    Wahl A; Praz F; Tai T; Findling O; Walpoth N; Nedeltchev K; Schwerzmann M; Windecker S; Mattle HP; Meier B
    Heart; 2010 Jun; 96(12):967-73. PubMed ID: 20538672
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Migraine with aura: a predictor of patent foramen ovale in children and adolescents.
    Choi DY; Shin DH; Cho KH; Lee SP; Park S
    Cephalalgia; 2013 May; 33(7):463-8. PubMed ID: 23439571
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of Residual Interatrial Shunt on Migraine Burden After Transcatheter Closure of Patent Foramen Ovale.
    Ben-Assa E; Rengifo-Moreno P; Al-Bawardy R; Kolte D; Cigarroa R; Cruz-Gonzalez I; Sakhuja R; Elmariah S; Pomerantsev E; Vaina LM; Ning M; Buonanno FS; Hung JW; Inglessis I; Palacios IF
    JACC Cardiovasc Interv; 2020 Feb; 13(3):293-302. PubMed ID: 32029246
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence of patent foramen ovale and migraine headache in adults with congenital heart disease with no known cardiac shunts.
    Volman M; Mojadidi MK; Gevorgyan R; Kaing A; Agrawal H; Tobis J
    Catheter Cardiovasc Interv; 2013 Mar; 81(4):643-7. PubMed ID: 22927216
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Migraine with aura and patent foramen ovale. A different clinical entity].
    Ramírez-Moreno JM; Casado-Naranjo I; Gómez M; Portilla J; Caballero M; Serrano A; Ojalvo MJ; Falcón A; Tena-Mora D; Calle M
    Neurologia; 2008 Oct; 23(8):503-10. PubMed ID: 18770055
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between migraine and patent foramen ovale: a study of 121 patients with migraine.
    Domitrz I; Mieszkowski J; Kamińska A
    Headache; 2007 Oct; 47(9):1311-8. PubMed ID: 17927647
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Residual shunt after percutaneous closure of patent foramen ovale with AMPLATZER occluder devices - influence of anatomic features: a transcranial Doppler and intracardiac echocardiography study.
    Marchese N; Pacilli MA; Inchingolo V; Fanelli R; Loperfido F; Vigna C
    EuroIntervention; 2013 Jul; 9(3):382-8. PubMed ID: 23872652
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Frequency of migraine headache relief following patent foramen ovale "closure" despite residual right-to-left shunt.
    Jesurum JT; Fuller CJ; Kim CJ; Krabill KA; Spencer MP; Olsen JV; Likosky WH; Reisman M
    Am J Cardiol; 2008 Oct; 102(7):916-20. PubMed ID: 18805122
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcatheter patent foramen ovale closure mitigates aura migraine headaches abolishing spontaneous right-to-left shunting.
    Giardini A; Donti A; Formigari R; Salomone L; Prandstraller D; Bonvicini M; Palareti G; Guidetti D; Gaddi O; Picchio FM
    Am Heart J; 2006 Apr; 151(4):922.e1-5. PubMed ID: 16569564
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Migraine Intervention With STARFlex Technology (MIST) trial: a prospective, multicenter, double-blind, sham-controlled trial to evaluate the effectiveness of patent foramen ovale closure with STARFlex septal repair implant to resolve refractory migraine headache.
    Dowson A; Mullen MJ; Peatfield R; Muir K; Khan AA; Wells C; Lipscombe SL; Rees T; De Giovanni JV; Morrison WL; Hildick-Smith D; Elrington G; Hillis WS; Malik IS; Rickards A
    Circulation; 2008 Mar; 117(11):1397-404. PubMed ID: 18316488
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Percutaneous Closure of Patent Foramen Ovale in Patients With Migraine: The PREMIUM Trial.
    Tobis JM; Charles A; Silberstein SD; Sorensen S; Maini B; Horwitz PA; Gurley JC
    J Am Coll Cardiol; 2017 Dec; 70(22):2766-2774. PubMed ID: 29191325
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is a predominant left-to-right shunt associated with migraine?: A prospective atrial septal defect closure study.
    Luermans JG; Post MC; Temmerman F; Thijs V; Schonewille WJ; Plokker HW; Ten Berg JM; Suttorp MJ; Budts WI
    Catheter Cardiovasc Interv; 2009 Dec; 74(7):1078-84. PubMed ID: 19739264
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of transcatheter closure of patent foramen ovale in the evolution of migraine and role of residual shunt.
    Biasco L; Infantino V; Orzan F; Vicentini S; Rovera C; Longo G; Chinaglia A; Belli R; Allais G; Gaita F
    J Cardiol; 2014 Nov; 64(5):390-4. PubMed ID: 24713153
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impaired endothelial function in patients with cryptogenic stroke and patent foramen ovale is not affected by closure.
    Lantz M; Kostulas K; Settergren M; Sjöstrand C
    J Interv Cardiol; 2017 Jun; 30(3):242-248. PubMed ID: 28439982
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.